Advanced lung testing detects hidden post-COVID respiratory dysfunction :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Persistent pulmonary sequelae detected after mild COVID-19, especially in adults

Mild COVID-19 in non-hospitalized adults and children Mild COVID-19 in non-hospitalized adults and children
Mild COVID-19 in non-hospitalized adults and children Mild COVID-19 in non-hospitalized adults and children

What's new?

Mild COVID-19 frequently causes persistent small airway dysfunction detectable by lung clearance index, even when spirometry and DLCO appear normal.
 

A new investigation into the long-term respiratory impact of mild COVID-19 reveals that while critical lung impairment is uncommon, subtle pulmonary dysfunction—particularly affecting ventilation distribution—can persist for months after infection, especially in adults.

The research evaluated pulmonary outcomes in 110 non-hospitalized patients (90 adults and 20 children) aged 6–60 years who had confirmed SARS-CoV-2 infection but no prior respiratory disease. Lung function was assessed 4–12 weeks after acute infection using:

  • Spirometry
  • Diffusing capacity of lungs for carbon monoxide (DLCO)
  • Lung clearance index (LCI)

To rule out co-infections, pharyngeal swabs were analyzed via multiplex polymerase chain reaction (PCR) for other acute respiratory pathogens. Patients with abnormal findings underwent repeat testing 3 months later. For validating the results, a retrospective z-score analysis of lung function parameters was also carried out.

At baseline, 50% of adults (45/90) and 85% of children (17/20) had at least one abnormal pulmonary function parameter. The LCI was the most frequently impaired parameter. At approximately 5 months post-infection, persistent abnormalities remained in:

  • 83.3% of adults (35/42)
  • 69.2% of children (9/13)

Respiratory symptoms such as dyspnoea and chest pain were linked with lower spirometry and DLCO values. Additional respiratory pathogens were detected in:

  • 40.3% (25 patients) with abnormal lung function
  • 43.5% (20 patients) with normal lung function

The retrospective z-score analysis closely mirrored the initial results. To sum up, critical pulmonary impairment following mild COVID-19 is rarely diagnosed by conventional spirometry and DLCO testing. However, abnormalities in LCI suggest subtle ventilation inhomogeneity that may not be captured by routine assessments.

Most patients demonstrate improvement within 3 months, yet a considerable proportion—particularly adults—continue to display abnormal lung function up to 5 months post-infection. Children appear less impacted by severe pulmonary sequelae and respiratory complaints compared to adults.

 

Source:

BMC Pulmonary Medicine

Article:

Pulmonary function in non-hospitalized adults and children after mild COVID-19: a single-centre prospective cohort study

Authors:

Alexandra R. Görges et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: